Trial intelligence / Profile preview

Tolvaptan for Hyponatremia in Hospitalized Patients

NCT01386372Phase 2Terminated

Sponsor
Mario Negri Institute for Pharmacological Research
Start
Jun 2011
Primary completion
Nov 2012
Countries
1
01

Overview

A Phase 2 trial of tolvaptan in hyponatremia, sponsored by Mario Negri Institute for Pharmacological Research. Started Jun 2011; status: terminated.

02

Drugs

tolvaptan
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT01386372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01386372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call